PC-PLC inhibition and exogenous NO delivery have both been shown to be decrease the activity of NF-κB, a transcription factor involved in the regulation of various genes associated with cancer cell survival, proliferation, angiogenesis, and metastasis [8,9,10,11,12,13,15,19,20,21]. This evidence concerns the gene NFKB1 and cancer.